| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 28.268 | 26.303 | 24.227 | 23.772 | 19.177 | 8.926 | 8.051 | 5.984 | 6.580 | 6.024 |
| Total Income - EUR | 28.404 | 26.369 | 24.330 | 23.785 | 19.291 | 9.429 | 8.051 | 5.984 | 6.580 | 6.024 |
| Total Expenses - EUR | 21.051 | 21.550 | 21.114 | 21.809 | 19.552 | 10.784 | 5.843 | 3.773 | 5.640 | 4.506 |
| Gross Profit/Loss - EUR | 7.354 | 4.820 | 3.216 | 1.976 | -261 | -1.355 | 2.209 | 2.211 | 940 | 1.518 |
| Net Profit/Loss - EUR | 6.502 | 4.292 | 2.486 | 1.738 | -454 | -1.431 | 2.186 | 2.032 | 809 | 1.284 |
| Employees | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Proteo Company Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 638 | 404 | 141 | 0 | 0 | 56 | 91 | 0 | 354 | 1.221 |
| Current Assets | 18.704 | 22.977 | 17.852 | 17.011 | 17.990 | 14.088 | 12.695 | 14.861 | 15.327 | 15.635 |
| Inventories | 14.214 | 14.519 | 16.107 | 13.175 | 13.799 | 11.544 | 10.044 | 10.055 | 9.215 | 10.189 |
| Receivables | 1.860 | 1.744 | 1.440 | 1.082 | 1.116 | 900 | 857 | 843 | 739 | 788 |
| Cash | 2.630 | 6.714 | 305 | 2.754 | 3.074 | 1.644 | 1.793 | 3.963 | 5.372 | 4.658 |
| Shareholders Funds | 14.114 | 18.262 | 17.155 | 13.207 | 12.497 | 10.829 | 12.775 | 14.847 | 15.611 | 16.807 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 5.228 | 5.119 | 837 | 3.804 | 5.493 | 3.314 | 11 | 15 | 70 | 48 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Proteo Company Srl